세계 피부 대체품·대용품 시장 : 시장 규모, 점유율 분석(제품별·클래스별·용도별·최종사용자별), 산업 수요 및 예측(-2030년)

Skin Replacements and Substitutes Market Size and Share Analysis by Product, Class, Application, End User - Global Industry Demand Forecast to 2030

US $ 4,900 ￦ 6,814,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 불가능합니다.

US $ 6,400 ￦ 8,901,000

Printable PDF (Group User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,400 ￦ 11,682,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 피부 대체품·대용품 시장 규모는 2024년부터 2030년에 걸쳐 복합 연간 성장률(CAGR) 7.0%를 기록할 전망이고 2030년까지 18억 6,920만 달러에 달할 것으로 예측되고 있습니다. 이 배경에는 외모의 아름다움에 돈을 쓰는 시민 증가, 화상의 발생률의 상승, 교통사고율 증가, 평균 수명의 급상승, 피부 질환이나 만성 질환의 유병률의 상승이 있습니다. WHO에 따르면 인도에서는 매년 100만명 가까이 중증·중등도의 화상을 입고 있습니다. 인도에서의 장애조정 생존연수의 높이는 화상을 비롯한 많은 원인으로 인한 것입니다.

외모의 아름다움에 대한 관심 증대 :

만성 질환 및 기타 이유로 피부에 손상을 입은 사람들은 외모를 아름답게 만드는 치료법을 찾습니다. 게다가 의료 분야의 기술 혁신은 무세포 피부 대체물과 같은 피부를 대체할 수 있는 다양한 제품을 이용할 수 있게 되었습니다. 이 제품에서는 나일론 메쉬가 진피로 작용하고 실리콘 멤브레인이 표피 역할을합니다. 그런 다음 돼지의 콜라겐에 이식되고 화학 결합에 의해 상처 바닥에 부착됩니다.

깊은 화상은 피부의 두 층(진피와 표피)을 파괴하고 미생물에 노출되기 때문에 감염과 추가 합병증을 유발할 수 있습니다. 따라서 신속한 의료지도와 수술이 권장됩니다. 살균 후 인공 피부는 파괴 된 조직을 재생시키기 위해 사이토 카인과 성장 인자의 방출을 촉진하는 능력이 있습니다. 이식편의 폭과 개구부, 연통 기공은 새로운 피부 재생에 이상적이어야합니다.

상처 치료 클리닉 및 병원 시장에서 우위를 지속:

상처 치료 클리닉과 병원은 정교한 장비, 전문가, 필요한 약제, 복잡한 열상 사례에 필요한 기술을 가지고 있기 때문에 가장 큰 최종 사용자입니다. 피부 질환을 앓고있는 사람이 증가함에 따라 이러한 의료 센터 방문자 수가 증가하고 있습니다. 또한, 심각한 상처는 수술 후 발생하기 때문에 이러한 피부 치환술은 종종 수술 후 치료 전반의 요법의 일부가됩니다.

아시아태평양 성장 기회:

북미는 의료 분야의 진보와 스킨 케어 수요의 높이에서 시장을 독점하고 있습니다. 게다가 대기업은 병원이나 미용센터, 상처치료클리닉과 연계하여 피부 대체품·대용품의 판매와 개발을 추진해 FDA의 승인 취득을 목표로 하고 있습니다. 예를 들어, 2021년 6월, Mallinckrodt Pharmaceuticals는 StrataGraft라는 새로운 피부 제품에 대한 FDA 승인을 받았습니다. 이 제품은 열에 의한 화상 후 피부 심층과 진피 요소의 일부가 손상되지 않은 상태로 남아있는 경우자가 이식의 필요성을 줄일 수 있습니다.

아시아태평양(APAC)은 미용 성형에 대한 수요가 증가하고 당뇨병 성 발궤양(DFU)과 같은 피부 질환의 유병률이 높아짐에 따라 가장 급성장하는 시장입니다. 당뇨병 인구의 15-25%가 어느 시점에서 DFU를 발병합니다. WHO에 따르면 중국의 당뇨병 인구는 2016년 1억 1,000만 명에서 2040년에는 1억 5,000만 명에 이를 것으로 예상됩니다. 또한 인도에서는 2019년부터 2021년에 걸쳐 3,100만명이 새롭게 당뇨병으로 진단되었습니다.

본 보고서에서는 세계 피부 대체품·대용품 시장에 대해 분석하고, 시장의 기본 구조·최신 정세나 주요한 촉진·억제요인, 세계 전체 및 지역별·주요국 시장 규모의 동향 전망(금액 기준)(2017년-2030년)), 제품별, 클래스별, 용도별, 최종 사용자별 상세 동향, 현재 시장 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 지표

제5장 업계 전망

• 시장 역학
  • 동향
  • 성장 촉진요인
  • 억제요인/과제
  • 성장 촉진요인/억제요인의 영향 분석
• 신형 코로나 바이러스 감염(COVID-19)의 영향
• Porter's Five Forces 분석

제6장 시장

• 개요
• 시장 수익 : 제품별(2017년-2030년)
• 시장 수익 : 클래스별(2017년-2030년)
  • 클래스 I 시장 수익 : 유형별(2017년-2030년)
  • 클래스 II 시장 수익 : 유형별(2017년-2030년)
  • 클래스 III 시장 수익 : 유형별(2017년-2030년)
• 시장 수익 : 용도별(2017년-2030년)
• 시장 수익 : 최종사용자별(2017년-2030년)
• 시장 수익 : 지역별(2017년-2030년)

제7장 북미 시장

• 개요
• 시장 수익 : 제품별(2017년-2030년)
• 시장 수익 : 클래스별(2017년-2030년)
  • 클래스 I 시장 수익 : 유형별(2017년-2030년)
  • 클래스 II 시장 수익 : 유형별(2017년-2030년)
  • 클래스 III 시장 수익 : 유형별(2017년-2030년)
• 시장 수익 : 용도별(2017년-2030년)
• 시장 수익 : 최종사용자별(2017년-2030년)
• 시장수익 : 국가별(2017년-2030년)

제8장 유럽 시장

제9장 아시아태평양 시장

제10장 라틴아메리카 시장

제11장 중동 및 아프리카(MEA) 시장

제12장 미국 시장

• 개요
• 시장 수익 : 제품별(2017년-2030년)
• 시장 수익 : 클래스별(2017년-2030년)
  • 클래스 I 시장 수익 : 유형별(2017년-2030년)
  • 클래스 II 시장 수익 : 유형별(2017년-2030년)
  • 클래스 III 시장 수익 : 유형별(2017년-2030년)
• 시장 수익 : 용도별(2017년-2030년)
• 시장 수익 : 최종사용자별(2017년-2030년)

제13장 캐나다 시장

제14장 독일 시장

제15장 프랑스 시장

제16장 영국 시장

제17장 이탈리아 시장

제18장 스페인 시장

제19장 일본 시장

제20장 중국 시장

제21장 인도 시장

제22장 호주 시장

제23장 한국 시장

제24장 브라질 시장

제25장 멕시코 시장

제26장 사우디아라비아 시장

제27장 남아프리카 시장

제28장 아랍에미리트(UAE) 시장

제29장 경쟁 구도

• 시장 진출기업과 그 제공 제품/서비스의 일람
• 주요 기업의 경쟁 벤치마킹
• 주요 기업의 제품 벤치마킹
• 최근의 전략 전개 상황

제30장 기업 프로파일

• Acelity LP Inc.
• MiMedx Group Inc.
• Organogenesis Inc.
• Vericel Corporation
• FUJIFILM Cellular Dynamics Inc.
• Smith & Nephew plc
• Integra LifeSciences Holdings Corporation
• AlloSource
• MatTek Corporation

제31장 부록

BJH

영문 목차

영문목차

The global skin replacements and substitutes market size is set to be USD 1,869.2 million by 2030, witnessing 7.0% CAGR between 2024 and 2030. This will be due to the increasing number of citizens spending on appearance enhancement, rising incidence of burns, growing rate of road accidents, surging life expectancy, and escalating prevalence of skin and chronic disease. As per the WHO, nearly 1 million people in India get severe and moderate burns each year. The high disability-adjusted life-years in India are due to burns and many other causes.

Increasing Focus on Enhance Appearance of Skin

People with skin damage due to chronic diseases and other reasons are increasingly seeking remedies to enhance their appearance. Further, due to the innovations in the healthcare sector, various products are available for use as skin replacement, such as acellular substitutes; these products are cost-effective and efficient. In these products, a nylon mesh works as the dermis, and a silicon membrane works as the epidermis. It is then implanted into porcine collagen and connected by chemical bonds for attachment to the wound base.

Deep burns can destroy both layers of the skin (dermis and epidermis), exposing them to microorganisms, which can cause infections and further complications. Therefore, quick medical guidance or surgery is advised. Artificial skin, after sterilization, has the capacity to enhance the release of cytokines and growth factors for regenerating the destroyed tissue. The width, orifice, and interconnecting pores of the graft should be ideal for the regeneration of new skin.

Continued Dominance of Wound Care Clinics and Hospitals on Market

Wound care clinics and hospitals are the largest end users as they have sophisticated facilities, expert professionals, necessary medication, and the technology required for complicated burn cases. With an increasing number of people suffering from dermatological diseases, the footfall at these healthcare centers is rising. Moreover, severe wounds are caused after surgery; hence, such skin replacement procedures are often part of the overall post-operative care regimen.

Growing Opportunities in APAC

North America is dominating the market due to the advancements in the healthcare sector and a high demand for skincare. Moreover, the key market players are collaborating with hospitals, cosmetic centers, and wound care clinics to sell and advance their skin replacement and substitute products and pursuing the approval of the FDA for them. For instance, in June 2021 Mallinckrodt Pharmaceuticals received the FDA approval for a novel skin product, called StrataGraft. It can reduce the requirement for autografts if some part of the deeper skin layers and dermal elements remains intact after a thermal burn injury.

APAC is the fastest-growing market due to the increasing demand for cosmetic procedures and the high prevalence of diabetic foot ulcers and other skin issues. Between 15 and 25% of the population with diabetes mellitus would develop a DFU at some point. As per the WHO, diabetic population in China is expected to reach 150 million by 2040 from 110 million in 2016. Moreover, India registered 31 million new diabetes diagnoses in 2019-2021.

Some of the key players in the skin and replacements and substitutes market are Acelity L.P. Inc., MiMedx Group Inc., Organogenesis Inc., Vericel Corporation, FUJIFILM Cellular Dynamics Inc., Smith & Nephew plc, Integra LifeSciences Holdings Corporation, AlloSource, and MatTek Corporation.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by class
  • 1.4.3. Market size breakdown, by application
  • 1.4.4. Market size breakdown, by end user
  • 1.4.5. Market size breakdown, by region
  • 1.4.6. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Class (2017-2030)
  • 6.3.1. Class I market revenue, by type (2017-2030)
  • 6.3.2. Class II market revenue, by type (2017-2030)
  • 6.3.3. Class III market revenue, by type (2017-2030)
• 6.4. Market Revenue, by Application (2017-2030)
• 6.5. Market Revenue, by End User (2017-2030)
• 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Class (2017-2030)
  • 7.3.1. Class I market revenue, by type (2017-2030)
  • 7.3.2. Class II market revenue, by type (2017-2030)
  • 7.3.3. Class III market revenue, by type (2017-2030)
• 7.4. Market Revenue, by Application (2017-2030)
• 7.5. Market Revenue, by End User (2017-2030)
• 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Class (2017-2030)
  • 8.3.1. Class I market revenue, by type (2017-2030)
  • 8.3.2. Class II market revenue, by type (2017-2030)
  • 8.3.3. Class III market revenue, by type (2017-2030)
• 8.4. Market Revenue, by Application (2017-2030)
• 8.5. Market Revenue, by End User (2017-2030)
• 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Class (2017-2030)
  • 9.3.1. Class I market revenue, by type (2017-2030)
  • 9.3.2. Class II market revenue, by type (2017-2030)
  • 9.3.3. Class III market revenue, by type (2017-2030)
• 9.4. Market Revenue, by Application (2017-2030)
• 9.5. Market Revenue, by End User (2017-2030)
• 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Class (2017-2030)
  • 10.3.1. Class I market revenue, by type (2017-2030)
  • 10.3.2. Class II market revenue, by type (2017-2030)
  • 10.3.3. Class III market revenue, by type (2017-2030)
• 10.4. Market Revenue, by Application (2017-2030)
• 10.5. Market Revenue, by End User (2017-2030)
• 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Class (2017-2030)
  • 11.3.1. Class I market revenue, by type (2017-2030)
  • 11.3.2. Class II market revenue, by type (2017-2030)
  • 11.3.3. Class III market revenue, by type (2017-2030)
• 11.4. Market Revenue, by Application (2017-2030)
• 11.5. Market Revenue, by End User (2017-2030)
• 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Class (2017-2030)
  • 12.3.1. Class I market revenue, by type (2017-2030)
  • 12.3.2. Class II market revenue, by type (2017-2030)
  • 12.3.3. Class III market revenue, by type (2017-2030)
• 12.4. Market Revenue, by Application (2017-2030)
• 12.5. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Class (2017-2030)
  • 13.3.1. Class I market revenue, by type (2017-2030)
  • 13.3.2. Class II market revenue, by type (2017-2030)
  • 13.3.3. Class III market revenue, by type (2017-2030)
• 13.4. Market Revenue, by Application (2017-2030)
• 13.5. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Class (2017-2030)
  • 14.3.1. Class I market revenue, by type (2017-2030)
  • 14.3.2. Class II market revenue, by type (2017-2030)
  • 14.3.3. Class III market revenue, by type (2017-2030)
• 14.4. Market Revenue, by Application (2017-2030)
• 14.5. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Class (2017-2030)
  • 15.3.1. Class I market revenue, by type (2017-2030)
  • 15.3.2. Class II market revenue, by type (2017-2030)
  • 15.3.3. Class III market revenue, by type (2017-2030)
• 15.4. Market Revenue, by Application (2017-2030)
• 15.5. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Class (2017-2030)
  • 16.3.1. Class I market revenue, by type (2017-2030)
  • 16.3.2. Class II market revenue, by type (2017-2030)
  • 16.3.3. Class III market revenue, by type (2017-2030)
• 16.4. Market Revenue, by Application (2017-2030)
• 16.5. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Class (2017-2030)
  • 17.3.1. Class I market revenue, by type (2017-2030)
  • 17.3.2. Class II market revenue, by type (2017-2030)
  • 17.3.3. Class III market revenue, by type (2017-2030)
• 17.4. Market Revenue, by Application (2017-2030)
• 17.5. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Class (2017-2030)
  • 18.3.1. Class I market revenue, by type (2017-2030)
  • 18.3.2. Class II market revenue, by type (2017-2030)
  • 18.3.3. Class III market revenue, by type (2017-2030)
• 18.4. Market Revenue, by Application (2017-2030)
• 18.5. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Class (2017-2030)
  • 19.3.1. Class I market revenue, by type (2017-2030)
  • 19.3.2. Class II market revenue, by type (2017-2030)
  • 19.3.3. Class III market revenue, by type (2017-2030)
• 19.4. Market Revenue, by Application (2017-2030)
• 19.5. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Class (2017-2030)
  • 20.3.1. Class I market revenue, by type (2017-2030)
  • 20.3.2. Class II market revenue, by type (2017-2030)
  • 20.3.3. Class III market revenue, by type (2017-2030)
• 20.4. Market Revenue, by Application (2017-2030)
• 20.5. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Class (2017-2030)
  • 21.3.1. Class I market revenue, by type (2017-2030)
  • 21.3.2. Class II market revenue, by type (2017-2030)
  • 21.3.3. Class III market revenue, by type (2017-2030)
• 21.4. Market Revenue, by Application (2017-2030)
• 21.5. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Class (2017-2030)
  • 22.3.1. Class I market revenue, by type (2017-2030)
  • 22.3.2. Class II market revenue, by type (2017-2030)
  • 22.3.3. Class III market revenue, by type (2017-2030)
• 22.4. Market Revenue, by Application (2017-2030)
• 22.5. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Class (2017-2030)
  • 23.3.1. Class I market revenue, by type (2017-2030)
  • 23.3.2. Class II market revenue, by type (2017-2030)
  • 23.3.3. Class III market revenue, by type (2017-2030)
• 23.4. Market Revenue, by Application (2017-2030)
• 23.5. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Class (2017-2030)
  • 24.3.1. Class I market revenue, by type (2017-2030)
  • 24.3.2. Class II market revenue, by type (2017-2030)
  • 24.3.3. Class III market revenue, by type (2017-2030)
• 24.4. Market Revenue, by Application (2017-2030)
• 24.5. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Class (2017-2030)
  • 25.3.1. Class I market revenue, by type (2017-2030)
  • 25.3.2. Class II market revenue, by type (2017-2030)
  • 25.3.3. Class III market revenue, by type (2017-2030)
• 25.4. Market Revenue, by Application (2017-2030)
• 25.5. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Class (2017-2030)
  • 26.3.1. Class I market revenue, by type (2017-2030)
  • 26.3.2. Class II market revenue, by type (2017-2030)
  • 26.3.3. Class III market revenue, by type (2017-2030)
• 26.4. Market Revenue, by Application (2017-2030)
• 26.5. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Class (2017-2030)
  • 27.3.1. Class I market revenue, by type (2017-2030)
  • 27.3.2. Class II market revenue, by type (2017-2030)
  • 27.3.3. Class III market revenue, by type (2017-2030)
• 27.4. Market Revenue, by Application (2017-2030)
• 27.5. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Class (2017-2030)
  • 28.3.1. Class I market revenue, by type (2017-2030)
  • 28.3.2. Class II market revenue, by type (2017-2030)
  • 28.3.3. Class III market revenue, by type (2017-2030)
• 28.4. Market Revenue, by Application (2017-2030)
• 28.5. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Acelity L.P. Inc.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. MiMedx Group Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Organogenesis Inc.
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Vericel Corporation
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. FUJIFILM Cellular Dynamics Inc.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Smith & Nephew plc
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Integra LifeSciences Holdings Corporation
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. AlloSource
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. MatTek Corporation
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports

관련자료